<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906776</url>
  </required_header>
  <id_info>
    <org_study_id>CR 01/05</org_study_id>
    <nct_id>NCT00906776</nct_id>
  </id_info>
  <brief_title>Emdogain and Straumann Bone Ceramic in Infrabony Defects</brief_title>
  <official_title>Randomised, Controlled, Clinical Study to Compare the Effect of a Combination of Enamel Matrix Proteins and Straumann Bone Ceramic With Autogenous Bone in Deep-wide Intrabony Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised, controlled, clinical study to compare the effect of the combination of bone&#xD;
      ceramic and enamel matrix proteins (test) versus autogenous bone graft alone (control) in the&#xD;
      treatment of deep-wide intrabony defects&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      30 subjects (15 test and 15 control) diagnosed with moderate to severe periodontitis&#xD;
      (Armitage, 1999) will be enrolled in the study and randomized to either the test or the&#xD;
      control group.&#xD;
&#xD;
      The surgical procedure shall be performed within 15 days from the baseline visit of the&#xD;
      subjects and will be the same for both groups. In both groups, the flap is replaced&#xD;
      subsequently.&#xD;
&#xD;
      In total 5 visits per patient are scheduled in this study. The total study duration for each&#xD;
      patient should be 12 +/- 2 weeks.&#xD;
&#xD;
      The study devices Emdogain® and Straumann Bone Ceramic are CE-marked, and approved by the&#xD;
      FDA.&#xD;
&#xD;
      One center in France will participate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty to recruit patients fulfilling inclusion criteria&#xD;
  </why_stopped>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Clinical Attachment Level (CAL)</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing Pocket Depth (PPD)</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Attachment Level (CAL)</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing Pocket Depth (PPD)</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Emdogain PLUS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autogenous bone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autogenous bone from the patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emdogain PLUS</intervention_name>
    <description>Emdogain treatment followed by Straumann Bone Ceramic application during periodontal surgery</description>
    <arm_group_label>Emdogain PLUS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autogenous bone</intervention_name>
    <description>Autogenous bone application during periodontal surgery</description>
    <arm_group_label>Autogenous bone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females must be at least 18 years and not more than 75 years of age&#xD;
&#xD;
          -  The patient will have to be able to understand and sign the informed consent prior to&#xD;
             starting the study.&#xD;
&#xD;
          -  The patient also will have to have the ability and the willingness to comply with all&#xD;
             study requirements.&#xD;
&#xD;
          -  The patients will be in good general health without any systemic diseases.&#xD;
&#xD;
          -  The teeth included in the study will be mandibular molars, maxillary and mandibular&#xD;
             premolars, and canines.&#xD;
&#xD;
          -  The patients will have to have at least one defect with pocket depth ≥ 5 mm.&#xD;
&#xD;
          -  Intra-bony defects will have to have 1 or 2-wall morphology (at least 2/3 of the&#xD;
             defect).&#xD;
&#xD;
          -  Depth of the intrabony component of at least 3 mm&#xD;
&#xD;
          -  The selected sites will have to have vertical intra-bony component ≥ 3 mm and an angle&#xD;
             ≥ 30 degrees as assessed from standardized intra-oral radiographs.&#xD;
&#xD;
          -  Oral hygiene parameters: Plaque Index (PI) ≤ 20 % and bleeding on probing (BoP) ≤ 20%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heavy smokers: more than 20 cigarettes per day&#xD;
&#xD;
          -  Mucosal diseases such as erosive lichen planus&#xD;
&#xD;
          -  History of local radiation therapy&#xD;
&#xD;
          -  Presence of oral lesions (such as ulceration, malignancy)&#xD;
&#xD;
          -  Teeth with untreated endodontic or cardiologic problems&#xD;
&#xD;
          -  Physical handicap that will interfere with patient's ability to exercise good oral&#xD;
             hygiene on a regular basis.&#xD;
&#xD;
          -  Patients presenting antibiotic treatment within the 3 months preceding the surgical&#xD;
             procedure.&#xD;
&#xD;
          -  Patients using anti-inflammatory drugs on a regular basis.&#xD;
&#xD;
          -  Intra-bony defects with a 3-wall morphology.&#xD;
&#xD;
          -  Intra-bony defects with furcation involvement.&#xD;
&#xD;
          -  Incisors and maxillary molars, will be excluded.&#xD;
&#xD;
          -  Alcoholism or chronically drug abuse causing systemic compromize&#xD;
&#xD;
          -  Medical conditions requiring prolonged use of steroids&#xD;
&#xD;
          -  Current pregnancy at the time of recruitment and/or breastfeeding women.&#xD;
&#xD;
          -  Conditions or circumstances, in the opinion of the investigator, which could represent&#xD;
             a general contra-indication for surgical procedure or would prevent completion of&#xD;
             study participation or interfere with analysis of study results, such as history of&#xD;
             non-compliance, or unreliability.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Bouchard, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rotschild Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôtel-Dieu, Université Paris 7 Denis Diderot</name>
      <address>
        <city>Paris</city>
        <zip>75006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>May 19, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <results_first_submitted>August 30, 2012</results_first_submitted>
  <results_first_submitted_qc>October 2, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2012</results_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="P2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="B2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.9" spread="8.9"/>
                    <measurement group_id="B2" value="31.9" spread="8.6"/>
                    <measurement group_id="B3" value="34.8" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Clinical Attachment Level (CAL)</title>
        <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level (CAL)</title>
          <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.86" spread="1.43"/>
                    <measurement group_id="O2" value="-2.44" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.02" spread="1.80"/>
                    <measurement group_id="O2" value="-2.13" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Probing Pocket Depth (PPD)</title>
        <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Pocket Depth (PPD)</title>
          <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.36" spread="1.42"/>
                    <measurement group_id="O2" value="-2.75" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Clinical Attachment Level (CAL)</title>
        <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level (CAL)</title>
          <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.44" spread="0.95"/>
                    <measurement group_id="O2" value="-2.25" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Probing Pocket Depth (PPD)</title>
        <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Pocket Depth (PPD)</title>
          <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.78" spread="1.18"/>
                    <measurement group_id="O2" value="-2.56" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.26" spread="1.99"/>
                    <measurement group_id="O2" value="-2.29" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="E2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Philippe Bouchard</name_or_title>
      <organization>Rotschild hospital</organization>
      <phone>+33614656947</phone>
      <email>phbouch@noos.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

